Bayer version of COVID-19 antimalarial hopeful may come with quality concerns: report
Drugmakers are rushing to supply millions of doses of hydroxychloroquine, a cheap generic in testing as a possible treatment for COVID-19, after public interest sent demand through the roof. But donated batches of the antimalarial drug from Bayer—which haven’t been approved by the FDA—are drawing quality concerns. The U.S. government has grown worried that millions of doses of… Read More »
